Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTRBUYN)

Molecule-Related Drug & Molecule List

Molecule-Related Drug List

Molecule Type:

DTT

DTP

DME

Drug Status:

Clinical Trial Drug(s)

Discontinued Drug(s)

Download the Complete Related Drug List

3 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
NTO-1151	DMRYLBW	Cervical cancer	2C77.0	Phase 2	[1]
Ranpirnase	DMM15RI	Lung cancer	2C25.0	Phase 2	[2]
MazF gene therapy	DMSZ8HT	Human immunodeficiency virus-1 infection	1C62	Phase 1	[3]
------------------------------------------------------------------------------------

1 Discontinued Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
AS-1406	DMRYQBE	Solid tumour/cancer	2A00-2F9Z	Terminated	[4]
------------------------------------------------------------------------------------

Molecule Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

References

1	Clinical pipeline report, company report or official report of Nanotherapeutics.
2	Ranpirnase (Onconase), a cytotoxic amphibian ribonuclease, manipulates tumour physiological parameters as a selective killer and a potential enhancer for chemotherapy and radiation in cancer therapy.Expert Opin Biol Ther. 2008 Jun;8(6):813-27.
3	Clinical pipeline report, company report or official report of Takara Bio.
4	WO patent application no. 2005,0657,17, Liquid formulations of antibody conjugates.